US 9169249
Protein kinase C inhibitors and uses thereof
granted A61KA61K31/506A61P
Quick answer
US patent 9169249 (Protein kinase C inhibitors and uses thereof) held by Rigel Pharmaceuticals, Inc. expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/506, A61P, A61P27/02, A61P29/00